Literature DB >> 15746185

The transport of cationic amino acids in human airway cells: expression of system y+L activity and transepithelial delivery of NOS inhibitors.

Bianca Maria Rotoli1, Ovidio Bussolati, Roberto Sala, Gian C Gazzola, Valeria Dall'Asta.   

Abstract

The transport of arginine has been characterized in human airway Calu-3 cells. As assessed with RT-PCR, Calu-3 cells express the genes for several transporters, such as the system y+-related SLC7A1, SLC7A2, and SLC7A4; the system y+L-related SLC7A6, SLC7A7, and SLC3A2; and the system B0,+-related SLC6A14. In polarized Calu-3 cell monolayers, apical arginine influx has a leucine-sensitive, sodium-dependent component and a leucine- and lysine-resistant sodium-independent fraction. At the basolateral membrane, arginine transport was fully sodium-independent and partially inhibited by leucine provided that sodium was present in the extracellular medium. Moreover, extracellular leucine trans-stimulated arginine efflux from the basolateral membrane in the presence, but not in the absence, of sodium. The transepithelial, apical to basolateral, arginine transport strictly depended on the presence of sodium and was markedly inhibited by apical leucine, but significantly trans-stimulated by the neutral amino acid added at the basolateral side. When added at the apical side, the NOS-inhibitors NMMA and NIL, CAA analogs with a free carboxyl group, markedly inhibited the apical arginine influx and the transepithelial flux of the cationic amino acid. The same compounds trans-stimulated basolateral arginine efflux. None of these effects were observed in the presence of the methyl ester analog NAME. The basolateral medium of Calu-3 cell monolayers, obtained after incubation in the presence of the three inhibitors at the apical side, inhibited the production of NO by activated murine macrophages. The inhibitory effect of the Calu-3 cell conditioned medium was time-dependent and markedly higher with NMMA and NIL than with NAME. Moreover, the NOS-inhibitory effect of the medium was significantly enhanced if NMMA and NIL, at the apical side, and basolateral leucine were simultaneously present during the conditioning procedure. These results indicate that 1) human airway epithelial cells express a functional system y+L at the basolateral membrane; 2) in this model, transepithelial arginine transport involves apical influx through system B0,+ and basolateral efflux through system y+L, and 3) the same transporters also perform an efficient transepithelial transport of amino acid-like NOS inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746185     DOI: 10.1096/fj.04-2924fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

1.  Modeling of cellular arginine uptake by more than one transporter.

Authors:  Marietha J Nel; Angela J Woodiwiss; Geoffrey P Candy
Journal:  J Membr Biol       Date:  2011-11-24       Impact factor: 1.843

2.  Arginine transport in human erythroid cells: discrimination of CAT1 and 4F2hc/y+LAT2 roles.

Authors:  Bianca Maria Rotoli; Ellen I Closs; Amelia Barilli; Rossana Visigalli; Alexandra Simon; Alice Habermeier; Nicoletta Bianchi; Roberto Gambari; Gian C Gazzola; Ovidio Bussolati; Valeria Dall'Asta
Journal:  Pflugers Arch       Date:  2009-06-28       Impact factor: 3.657

3.  Inhaled Sargramostim Induces Resolution of Pulmonary Alveolar Proteinosis in Lysinuric Protein Intolerance.

Authors:  Laura M Tanner; Johanna Kurko; Maaria Tringham; Heikki Aho; Juha Mykkänen; Kirsti Näntö-Salonen; Harri Niinikoski; Heikki Lukkarinen
Journal:  JIMD Rep       Date:  2016-10-26

Review 4.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages.

Authors:  Amelia Barilli; Bianca Maria Rotoli; Rossana Visigalli; Ovidio Bussolati; Gian C Gazzola; Zamir Kadija; Giuseppe Rodi; Francesca Mariani; Maria Lorena Ruzza; Maurizio Luisetti; Valeria Dall'Asta
Journal:  Orphanet J Rare Dis       Date:  2010-11-26       Impact factor: 4.123

6.  Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma.

Authors:  Alan R Penheiter; Sibel Erdogan; Stephen J Murphy; Steven N Hart; Joema Felipe Lima; Fariborz Rakhshan Rohakhtar; Daniel R O'Brien; William R Bamlet; Ryan E Wuertz; Thomas C Smyrk; Fergus J Couch; George Vasmatzis; Claire E Bender; Stephanie K Carlson
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

7.  Organic Cation Transporters (OCTs) in EpiAirway™, A Cellular Model of Normal Human Bronchial Epithelium.

Authors:  Amelia Barilli; Rossana Visigalli; Francesca Ferrari; Maria Di Lascia; Benedetta Riccardi; Paola Puccini; Valeria Dall'Asta; Bianca Maria Rotoli
Journal:  Biomedicines       Date:  2020-05-19

8.  Analysis of LPI-causing mutations on y+LAT1 function and localization.

Authors:  Bianca Maria Rotoli; Amelia Barilli; Filippo Ingoglia; Rossana Visigalli; Massimiliano G Bianchi; Francesca Ferrari; Diego Martinelli; Carlo Dionisi-Vici; Valeria Dall'Asta
Journal:  Orphanet J Rare Dis       Date:  2019-03-04       Impact factor: 4.123

9.  y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance.

Authors:  Bianca Maria Rotoli; Amelia Barilli; Rossana Visigalli; Francesca Ferrari; Valeria Dall'Asta
Journal:  J Cell Mol Med       Date:  2019-11-09       Impact factor: 5.310

10.  Downregulation of SLC7A7 Triggers an Inflammatory Phenotype in Human Macrophages and Airway Epithelial Cells.

Authors:  Bianca Maria Rotoli; Amelia Barilli; Rossana Visigalli; Filippo Ingoglia; Marco Milioli; Maria Di Lascia; Benedetta Riccardi; Paola Puccini; Valeria Dall'Asta
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.